First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study

Por Douillard, J-Y, Ostoros, G, Cobo, M, Ciuleanu, T, McCormack, R, Webster, A, Milenkova, T
Publicado em 2014

Performance on emotional tasks engaging cognitive control depends on emotional intelligence abilities: an ERP study

Por Megías, A., Gutiérrez-Cobo, M. J., Gómez-Leal, R., Cabello, R., Fernández-Berrocal, P.
Publicado no Sci Rep (2017)

SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015

Por García-Campelo, R., Bernabé, R., Cobo, M., Corral, J., Coves, J., Dómine, M., Nadal, E., Rodriguez-Abreu, D., Viñolas, N., Massuti, B.
Publicado no Clin Transl Oncol (2015)